<DOC>
	<DOCNO>NCT02365701</DOCNO>
	<brief_summary>This study evaluate efficacy investigational drug Motilitone 90 mg patient Functional Dyspepsia measure change maximum tolerate volume aggregate symptom score nutrient drink test .</brief_summary>
	<brief_title>Study Motilitone Treat Functional Dyspepsia</brief_title>
	<detailed_description />
	<mesh_term>Dyspepsia</mesh_term>
	<criteria>( 1 ) Subject fulfil Rome III criterion Functional Dyspepsia : They must one following : 1 . Bothersome postprandial fullness 2 . Early satiation 3 . Epigastric pain 4 . Epigastric burning AND No evidence structural disease upper endoscopy within last 3 month likely explain symptom These must fulfil last 3 month symptom onset least 6 month prior diagnosis . ( 2 ) At least moderate severe level within previous 3 month two follow eight symptom : upper abdominal pain , upper abdominal discomfort , postprandial fullness , upper abdominal bloating , early satiation , nausea , vomit excessive belching ( symptom rat 0 : None , 1 : Mild , 2 : Moderate , 3 : Severe ) . ( 3 ) Subjects able provide write informed consent . ( 1 ) Subject currently medication another study participate another clinical trial study within 4 week start study . ( 2 ) Women childbearing potential use contraception pregnant lactating woman . ( 3 ) Subject surgery may affect gastrointestinal motility . ( 4 ) Subject know history gastric bleeding , intestinal obstruction perforation . ( 5 ) Subject know history celiac disease , inflammatory bowel disease ( Crohn 's disease , ulcerative colitis ) microscopic colitis . ( 6 ) Subject diseases reflux esophagitis , gastroduodenal ulcer , gastric adenocarcinoma , esophageal adenocarcinoma , pancreatic disease , etc . may organic cause dyspepsia . ( 7 ) Subject liver dysfunction ( serum glutamic oxaloacetic transaminase/serum glutamic pyruvic transaminase least 2.5 time higher ULN ) . ( 8 ) Subject renal dysfunction ( Serum creatinine level least 1.5 time higher ULN ) . ( 9 ) Subject serious cardiovascular ( include know baseline QT prolongation define &gt; 450 msec ) respiratory illness . ( 10 ) Subject diagnose psychotic illness , substance dependence alcoholism . ( 11 ) Subject currently take drug may affect gastrointestinal motility ( e.g. , anticholinergic , Reglan , erythromycin , azithromycin , Domperidone , etc . ) , Buspirone , Acotiamide , Tramadol , nonsteroidal antiinflammatory drug , systemic corticosteroid , antidepressant , etc . within last 2 week randomization . ( 12 ) Medications affect QT within last 2 week randomization . ( 13 ) Subjects herbal supplement Functional Dyspepsia within last 2 week randomization . ( 14 ) Subjects gastric electric stimulator place . ( 15 ) Subjects narcotics benzodiazepine within 7 day randomization . ( 16 ) Subjects score &gt; 12 anxiety depression Hospital Anxiety Depression Scale ( HADS ) . ( 17 ) Vulnerable study population</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Functional Dyspepsia</keyword>
</DOC>